AI Agents for Clinical Trial Matching in Healthcare

Shows how an AI agent can autonomously identify eligible patients and match them to trials, using data mapping, eligibility logic, and audit trails.

By Suhas Bhairav · Updated

Direct Answer

AI agents for clinical trial matching in healthcare are goal driven software that identify eligible patients, map data from electronic health records, query eligibility rules, run risk checks, and hand off to coordinators. Core tools are EHR parsers, IRB-compliant data stores, and trial registries; results stay with clinicians.

Best for: Clinical operations teams, data engineers, and research coordinators.

What AI Agents Can Do in Clinical Trial Matching in Healthcare

  • Data intake and normalization

    Ingest patient data from EHR feeds, map to common data fields, validate formats, and prepare a unified profile for eligibility assessment, then pass to the eligibility module.

  • Eligibility screening

    Apply trial inclusion/exclusion criteria against the unified profile, flag borderline cases, and compile a shortlist of potential trials with confidence levels for review.

  • Trial matching

    Cross-reference candidate patients with active trials, extract key criteria like disease stage and biomarkers, and assemble candidate lists with contact and trial identifiers for outreach.

  • Scheduling and matching

    Coordinate potential visits or remote screenings, align patient calendars with site availability, and generate an action plan for coordinators with required documents.

  • Compliance and auditing

    Record provenance of data, log decisions, flag noncompliant data, and generate audit-ready summaries for IRB and sponsor review.

  • Reporting and handoff

    Produce clinician-ready briefs, export to case management systems, and hand off active candidates with next-step tasks and deadlines.

How the Agent Works

  1. Receive the goal

    The agent accepts a clinical trial matching objective, such as two patients per week for a disease area, and retrieves current trial listings, inclusion criteria, and site constraints.

  2. Plan

    The agent designs a plan to ingest patient data, map fields to standardized models, and outline criteria checks, while logging sensitivity levels and data access requirements.

  3. Call tools

    It invokes EHR interfaces, data normalization modules, and trial registries to build candidate profiles and retrieve trial eligibility rules.

  4. Check the result

    The agent validates results, verifies data quality, and scores match confidence, then iterates with additional data requests if needed.

  5. Finish or hand off

    If criteria are met, it hands off to the coordinator with a prioritized list; otherwise it produces a report explaining gaps and recommended actions.

Worked Example

Matching a patient to an eligible trial and scheduling a screening

Illustrative scenario with sample data.

Scenario

A mid-sized hospital system implements an AI agent to identify eligible patients for a phase II oncology trial and to schedule initial screening visits.

Input

patientData: {id: 98765, age: 58, diagnosis: 'metastatic breast cancer', biomarkers: ['BRCA1-negative'], priorTreatments: ['taxane'], consentStatus: 'consented'}; trialListings: [{id:'T-001', disease:'breast cancer', phase:2, criteria:['age 18-75','BRCA1-negative','priorTaxane'], siteAvailability:['SiteA','SiteB']}]

What the agent does

  1. Tool: EHR ingest; returns mapped profile and data gaps; agent decides to request missing allergy data.
  2. Tool: Eligibility engine; returns match result with status 'eligible' for trial T-001 and notes a data gap on lab results; the agent requests updated labs immediately.
  3. Tool: Registry query; returns trial T-001 active and site availability at SiteA; the agent assigns SiteA visit and schedules initial screening window. Review notes added for patient coordinator.
  4. Tool: Scheduling module; returns proposed screening date at SiteA and required visit documents; the agent approves, routes to coordinating staff, and sends patient notification with next steps.

Output

Record created: patient 98765 matched to trial T-001 with eligibility status eligible, site SiteA available, screening date proposed as 2026-11-20, required labs updated, consent verified, data provenance logged.

Human decision

IRB-approved data fields and completeness must be confirmed; a clinician reviewer should sign off on the final candidate list and confirm consent status before outreach.

What You Need

  • Access to electronic health record feeds and standardized data models for patient profiles.
  • Access to trial registries and site schedules with read permissions.
  • Clear data governance and consent status handling per IRB rules.
  • Comprehensive activity logs and audit trail storage for compliance.

Where People Stay in Charge

  • The agent operates under defined data governance rules and must not override clinician judgments; a reviewer must approve trial suitability in edge cases.
  • Any decision involving risky interventions or biomarker retries requires a clinician sign-off before outreach or enrollment.
  • Final outreach and patient communication should always be performed by a human coordinator after the agent proposes candidates.

FAQ

What is AI used for in clinical trial matching?

AI assists by ingesting patient data from EHRs, applying trial eligibility criteria, and producing candidate lists with next-step actions. A clinician reviews edge cases before outreach, ensuring alignment with consent and safety requirements.

What data sources does the agent use for matching?

The agent uses structured EHR fields, lab results, biomarker data, prior treatments, and disease staging, plus trial registry records and site availability to assemble candidates and schedule initial screenings.

How is patient privacy protected?

Data handling follows governance rules, with role-based access, encryption in transit and at rest, and audit trails showing who accessed or modified data; clinician review remains for consent verification.

When does a human step in?

A clinician reviews edge cases where eligibility is borderline, data gaps exist, or consent or safety considerations require confirmation before outreach or enrollment actions.